The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Canine Arthritis Treatment Market Research Report 2025
Synopsis
The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly used canine arthritis treatment drugs. NSAIDs are used to treat mild to moderate pain by reducing the production of prostaglandins, which is involved with inflammation and discomfort. Several non-steroidal anti-inflammatory medications approved for canine arthritis treatment are Ketaprofen, Carprofen, Deracoxib, and Rimadyl, among others. Opioids are another class of pain relief medication for canine arthritis treatment, which includes Tramadol, Tapentadol, and buprenorphine, among others. Opioids work by acting through the central opioid receptors. They are used to treat moderate to severe as well as chronic pain associated with arthritis. The stem cell therapy is a new treatment option for canine arthritis treatment. The stem cell Canine Arthritis Treatment is usually performed as canine arthritis treatment using either autologous stem cells or allogeneic stem cells Canine Arthritis Treatment. In the stem cell canine arthritis treatment, the adult stem cells are harvested from canine’s fat tissues and injected into the affected joints. The stem cell Canine Arthritis Treatment has improved the quality of life of canines by reducing pain and increasing mobility and has shown 85% success rate within 5 months of canine arthritis treatment.
The global Canine Arthritis Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Canine Arthritis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Canine Arthritis Treatment.
Report Scope
The Canine Arthritis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Canine Arthritis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Canine Arthritis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Elanco (Eli Lilly and Company)
Boehringer Ingelheim
Zoetis Inc
Vetoquinol S.A.
Bayer AG
Aratana Therapeutics Inc
Norbrook Laboratories Limited
VetStem Biopharma
Dechra Pharmaceuticals Plc
Segment by Type
Non-Steroidal Anti-Inflammatory Drugs
Opioids
Segment by Application
Veterinary Hospitals and Clinics
Drug Stores
E-commerce
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Canine Arthritis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The canine arthritis treatment types include non-steroidal anti-inflammatory medications (NSAIDs), opioids and stem cell Canine Arthritis Treatment. Non-steroidal anti-inflammatory Canine Arthritis Treatment are used to control pain and inflammation associated with arthritis. They are most commonly used canine arthritis treatment drugs. NSAIDs are used to treat mild to moderate pain by reducing the production of prostaglandins, which is involved with inflammation and discomfort. Several non-steroidal anti-inflammatory medications approved for canine arthritis treatment are Ketaprofen, Carprofen, Deracoxib, and Rimadyl, among others. Opioids are another class of pain relief medication for canine arthritis treatment, which includes Tramadol, Tapentadol, and buprenorphine, among others. Opioids work by acting through the central opioid receptors. They are used to treat moderate to severe as well as chronic pain associated with arthritis. The stem cell therapy is a new treatment option for canine arthritis treatment. The stem cell Canine Arthritis Treatment is usually performed as canine arthritis treatment using either autologous stem cells or allogeneic stem cells Canine Arthritis Treatment. In the stem cell canine arthritis treatment, the adult stem cells are harvested from canine’s fat tissues and injected into the affected joints. The stem cell Canine Arthritis Treatment has improved the quality of life of canines by reducing pain and increasing mobility and has shown 85% success rate within 5 months of canine arthritis treatment.
The global Canine Arthritis Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Canine Arthritis Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Canine Arthritis Treatment.
Report Scope
The Canine Arthritis Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Canine Arthritis Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Canine Arthritis Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Elanco (Eli Lilly and Company)
Boehringer Ingelheim
Zoetis Inc
Vetoquinol S.A.
Bayer AG
Aratana Therapeutics Inc
Norbrook Laboratories Limited
VetStem Biopharma
Dechra Pharmaceuticals Plc
Segment by Type
Non-Steroidal Anti-Inflammatory Drugs
Opioids
Segment by Application
Veterinary Hospitals and Clinics
Drug Stores
E-commerce
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Canine Arthritis Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Canine Arthritis Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Non-Steroidal Anti-Inflammatory Drugs
1.2.3 Opioids
1.3 Market by Application
1.3.1 Global Canine Arthritis Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Veterinary Hospitals and Clinics
1.3.3 Drug Stores
1.3.4 E-commerce
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Canine Arthritis Treatment Market Perspective (2019-2030)
2.2 Canine Arthritis Treatment Growth Trends by Region
2.2.1 Global Canine Arthritis Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Canine Arthritis Treatment Historic Market Size by Region (2019-2024)
2.2.3 Canine Arthritis Treatment Forecasted Market Size by Region (2025-2030)
2.3 Canine Arthritis Treatment Market Dynamics
2.3.1 Canine Arthritis Treatment Industry Trends
2.3.2 Canine Arthritis Treatment Market Drivers
2.3.3 Canine Arthritis Treatment Market Challenges
2.3.4 Canine Arthritis Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Canine Arthritis Treatment Players by Revenue
3.1.1 Global Top Canine Arthritis Treatment Players by Revenue (2019-2024)
3.1.2 Global Canine Arthritis Treatment Revenue Market Share by Players (2019-2024)
3.2 Global Canine Arthritis Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Canine Arthritis Treatment Revenue
3.4 Global Canine Arthritis Treatment Market Concentration Ratio
3.4.1 Global Canine Arthritis Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Canine Arthritis Treatment Revenue in 2023
3.5 Canine Arthritis Treatment Key Players Head office and Area Served
3.6 Key Players Canine Arthritis Treatment Product Solution and Service
3.7 Date of Enter into Canine Arthritis Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Canine Arthritis Treatment Breakdown Data by Type
4.1 Global Canine Arthritis Treatment Historic Market Size by Type (2019-2024)
4.2 Global Canine Arthritis Treatment Forecasted Market Size by Type (2025-2030)
5 Canine Arthritis Treatment Breakdown Data by Application
5.1 Global Canine Arthritis Treatment Historic Market Size by Application (2019-2024)
5.2 Global Canine Arthritis Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Canine Arthritis Treatment Market Size (2019-2030)
6.2 North America Canine Arthritis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Canine Arthritis Treatment Market Size by Country (2019-2024)
6.4 North America Canine Arthritis Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Canine Arthritis Treatment Market Size (2019-2030)
7.2 Europe Canine Arthritis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Canine Arthritis Treatment Market Size by Country (2019-2024)
7.4 Europe Canine Arthritis Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Canine Arthritis Treatment Market Size (2019-2030)
8.2 Asia-Pacific Canine Arthritis Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Canine Arthritis Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific Canine Arthritis Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Canine Arthritis Treatment Market Size (2019-2030)
9.2 Latin America Canine Arthritis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Canine Arthritis Treatment Market Size by Country (2019-2024)
9.4 Latin America Canine Arthritis Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Canine Arthritis Treatment Market Size (2019-2030)
10.2 Middle East & Africa Canine Arthritis Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Canine Arthritis Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa Canine Arthritis Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Elanco (Eli Lilly and Company)
11.1.1 Elanco (Eli Lilly and Company) Company Detail
11.1.2 Elanco (Eli Lilly and Company) Business Overview
11.1.3 Elanco (Eli Lilly and Company) Canine Arthritis Treatment Introduction
11.1.4 Elanco (Eli Lilly and Company) Revenue in Canine Arthritis Treatment Business (2019-2024)
11.1.5 Elanco (Eli Lilly and Company) Recent Development
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Detail
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Canine Arthritis Treatment Introduction
11.2.4 Boehringer Ingelheim Revenue in Canine Arthritis Treatment Business (2019-2024)
11.2.5 Boehringer Ingelheim Recent Development
11.3 Zoetis Inc
11.3.1 Zoetis Inc Company Detail
11.3.2 Zoetis Inc Business Overview
11.3.3 Zoetis Inc Canine Arthritis Treatment Introduction
11.3.4 Zoetis Inc Revenue in Canine Arthritis Treatment Business (2019-2024)
11.3.5 Zoetis Inc Recent Development
11.4 Vetoquinol S.A.
11.4.1 Vetoquinol S.A. Company Detail
11.4.2 Vetoquinol S.A. Business Overview
11.4.3 Vetoquinol S.A. Canine Arthritis Treatment Introduction
11.4.4 Vetoquinol S.A. Revenue in Canine Arthritis Treatment Business (2019-2024)
11.4.5 Vetoquinol S.A. Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Detail
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Canine Arthritis Treatment Introduction
11.5.4 Bayer AG Revenue in Canine Arthritis Treatment Business (2019-2024)
11.5.5 Bayer AG Recent Development
11.6 Aratana Therapeutics Inc
11.6.1 Aratana Therapeutics Inc Company Detail
11.6.2 Aratana Therapeutics Inc Business Overview
11.6.3 Aratana Therapeutics Inc Canine Arthritis Treatment Introduction
11.6.4 Aratana Therapeutics Inc Revenue in Canine Arthritis Treatment Business (2019-2024)
11.6.5 Aratana Therapeutics Inc Recent Development
11.7 Norbrook Laboratories Limited
11.7.1 Norbrook Laboratories Limited Company Detail
11.7.2 Norbrook Laboratories Limited Business Overview
11.7.3 Norbrook Laboratories Limited Canine Arthritis Treatment Introduction
11.7.4 Norbrook Laboratories Limited Revenue in Canine Arthritis Treatment Business (2019-2024)
11.7.5 Norbrook Laboratories Limited Recent Development
11.8 VetStem Biopharma
11.8.1 VetStem Biopharma Company Detail
11.8.2 VetStem Biopharma Business Overview
11.8.3 VetStem Biopharma Canine Arthritis Treatment Introduction
11.8.4 VetStem Biopharma Revenue in Canine Arthritis Treatment Business (2019-2024)
11.8.5 VetStem Biopharma Recent Development
11.9 Dechra Pharmaceuticals Plc
11.9.1 Dechra Pharmaceuticals Plc Company Detail
11.9.2 Dechra Pharmaceuticals Plc Business Overview
11.9.3 Dechra Pharmaceuticals Plc Canine Arthritis Treatment Introduction
11.9.4 Dechra Pharmaceuticals Plc Revenue in Canine Arthritis Treatment Business (2019-2024)
11.9.5 Dechra Pharmaceuticals Plc Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
